搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Microcystis aeruginosa Putative 8-amino-7-oxononanoate synthase (bioF) CSB-YP532089MTQ
CSB-EP532089MTQ
CSB-BP532089MTQ
CSB-MP532089MTQ
CSB-EP532089MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa NAD (P)H-quinone oxidoreductase subunit O CSB-YP532090MTQ
CSB-EP532090MTQ
CSB-BP532090MTQ
CSB-MP532090MTQ
CSB-EP532090MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa ATP phosphoribosyltransferase regulatory subunit (hisZ) CSB-YP532091MTQ
CSB-EP532091MTQ
CSB-BP532091MTQ
CSB-MP532091MTQ
CSB-EP532091MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa DNA mismatch repair protein mutL (mutL), partial CSB-YP532092MTQ
CSB-EP532092MTQ
CSB-BP532092MTQ
CSB-MP532092MTQ
CSB-EP532092MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa 30S ribosomal protein S12 (rpsL) CSB-YP532093MTQ
CSB-EP532093MTQ
CSB-BP532093MTQ
CSB-MP532093MTQ
CSB-EP532093MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa 50S ribosomal protein L35 (rpmI) CSB-YP532094MTQ
CSB-EP532094MTQ
CSB-BP532094MTQ
CSB-MP532094MTQ
CSB-EP532094MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa UPF0296 protein MAE_11840 (MAE_11840) CSB-YP532095MTQ
CSB-EP532095MTQ
CSB-BP532095MTQ
CSB-MP532095MTQ
CSB-EP532095MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa Phosphoglycerate kinase (pgk) CSB-YP532096MTQ
CSB-EP532096MTQ
CSB-BP532096MTQ
CSB-MP532096MTQ
CSB-EP532096MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa SsrA-binding protein (smpB) CSB-YP532097MTQ
CSB-EP532097MTQ
CSB-BP532097MTQ
CSB-MP532097MTQ
CSB-EP532097MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa Serine--tRNA ligase (serS) CSB-YP532098MTQ
CSB-EP532098MTQ
CSB-BP532098MTQ
CSB-MP532098MTQ
CSB-EP532098MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa Bifunctional protein pyrR (pyrR) CSB-YP532099MTQ
CSB-EP532099MTQ
CSB-BP532099MTQ
CSB-MP532099MTQ
CSB-EP532099MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa Bifunctional protein FolD (folD) CSB-YP532100MTQ
CSB-EP532100MTQ
CSB-BP532100MTQ
CSB-MP532100MTQ
CSB-EP532100MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa Light-independent protochlorophyllide reductase iron-sulfur ATP-binding protein (chlL) CSB-YP532101MTQ
CSB-EP532101MTQ
CSB-BP532101MTQ
CSB-MP532101MTQ
CSB-EP532101MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa Ribulose bisphosphate carboxylase large chain (cbbL) CSB-YP532102MTQ
CSB-EP532102MTQ
CSB-BP532102MTQ
CSB-MP532102MTQ
CSB-EP532102MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa Putative ribosome biogenesis GTPase RsgA (rsgA) CSB-YP532103MTQ
CSB-EP532103MTQ
CSB-BP532103MTQ
CSB-MP532103MTQ
CSB-EP532103MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa Sugar fermentation stimulation protein homolog (sfsA) CSB-YP532104MTQ
CSB-EP532104MTQ
CSB-BP532104MTQ
CSB-MP532104MTQ
CSB-EP532104MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa Gamma-glutamyl phosphate reductase (proA) CSB-YP532105MTQ
CSB-EP532105MTQ
CSB-BP532105MTQ
CSB-MP532105MTQ
CSB-EP532105MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa Photosystem II reaction center protein I (psbI), partial CSB-YP532106MTQ
CSB-EP532106MTQ
CSB-BP532106MTQ
CSB-MP532106MTQ
CSB-EP532106MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa Tryptophan synthase alpha chain (trpA) CSB-YP532107MTQ
CSB-EP532107MTQ
CSB-BP532107MTQ
CSB-MP532107MTQ
CSB-EP532107MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcystis aeruginosa 30S ribosomal protein S13 (rpsM) CSB-YP532108MTQ
CSB-EP532108MTQ
CSB-BP532108MTQ
CSB-MP532108MTQ
CSB-EP532108MTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>